Other research suggests that ATP13A2 may serve as a novel prognostic biomarker for colon cancer and a potential target for colon cancer therapy due to increased expression of ATP13A2 linking to shorter overall survival of colon cancer patients (Chen et al., 2020). Here, ATP13A2 is linked to colonic neoplasm.